Blistering disease: insight from the hemidesmosome and other components of the dermal-epidermal junction

Cell and Tissue Research

Volumn 360, Issue 3, 2015, Pages 545-569

  Turcan, Iana ^a   Jonkman, Marcel F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Bullous disease; Dermal epidermal junction; Epidermolysis bullosa; Hemidesmosome; Pemphigoid

Indexed keywords

ALPHA3 INTEGRIN; ALPHA6BETA4 INTEGRIN; AZATHIOPRINE; BP180 PROTEIN; BULLOUS PEMPHIGOID ANTIGEN 1; CD151 ANTIGEN; COLCHICINE; COLLAGEN TYPE 7; CORTICOSTEROID; CYCLOSPORIN; CYTOKERATIN 14; CYTOKERATIN 5; DAPSONE; IMMUNOGLOBULIN; KALININ; KINDLIN 1; LAMININ; LAMININ GAMMA1; METHOTREXATE; MYCOPHENOLATE MOFETIL; NICOTINAMIDE; NOTCH3 RECEPTOR; PLECTIN; RITUXIMAB; TETRACYCLINE; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 3;

ALPHA6BETA4 GENE; AMINO TERMINAL SEQUENCE; BLISTER; BULLOUS PEMPHIGOID; CARBOXY TERMINAL SEQUENCE; CD151 GENE; CELL DIFFERENTIATION; CELL MIGRATION; CELL ORGANELLE; CELL SURVIVAL; COL17A1 GENE; COL7A1 GENE; DDEB GENE; DERMOEPIDERMAL JUNCTION; DESMOSOME; DISEASE ASSOCIATION; DST GENE; EPIDERMOLYSIS BULLOSA; EPIDERMOLYSIS BULLOSA ACQUISITA; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EPIDERMOLYSIS BULLOSA SIMPLEX; FERMT1 GENE; GENE; GENE MUTATION; HEMIDESMOSOME; HUMAN; IMMUNOPATHOGENESIS; ITGA6 GENE; ITGB4 GENE; JEB GENE; KRT14 GENE; KRT5 GENE; LAMA3 GENE; LAMB3 GENE; LAMC2 GENE; LAMC3 GENE; LICHEN PLANUS PEMPHIGOIDES; MISSENSE MUTATION; MUCOUS MEMBRANE PEMPHIGOID; MUSCULAR DYSTROPHY; NONHUMAN; NOTCH3 GENE; PEMPHIGOID GESTATIONIS; PLEC GENE; PLECTIN DEFICIENCY; POIKILODERMA; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN STABILITY; RDEB GENE; REVIEW; SIGNAL TRANSDUCTION; TREATMENT INDICATION; ANIMAL; BIOLOGICAL MODEL; DERMIS; EPIDERMIS; GENETIC DISORDER; PATHOLOGY;

ANIMALS; BLISTER; DERMIS; EPIDERMIS; GENETIC DISEASES, INBORN; HEMIDESMOSOMES; HUMANS; MODELS, BIOLOGICAL;

EID: 84930273102     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-014-2021-7     Document Type: Review

References (305)

1. Abrams ML, Smidt A, Benjamin L, Chen M, Woodley D, Mancini AJ (2011) Congenital epidermolysis bullosa acquisita: vertical transfer of maternal autoantibody from mother to infant. Arch Dermatol 147:337–341
2. Ahmed AR, Kurgis BS, Rogers RS 3rd (1991) Cicatricial pemphigoid. J Am Acad Dermatol 24:987–1001
3. Al-Mutairi N, Sharma AK, Zaki A, El-Adawy E, Al-Sheltawy M, Nour-Eldin O (2004) Maternal and neonatal pemphigoid gestationis. Clin Exp Dermatol 29:202–204
4. Alonso-Llamazares J, Rogers RS 3rd, Oursler JR, Calobrisi SD (1998) Bullous pemphigoid presenting as generalized pruritus: observations in six patients. Int J Dermatol 37:508–514
5. Amato L, Mei S, Gallerani I, Moretti S, Fabbri P (2003) A case of chronic herpes gestationis: persistent disease or conversion to bullous pemphigoid? J Am Acad Dermatol 49:302–307
6. Ambros-Rudolph CM, Mullegger RR, Vaughan-Jones SA, Kerl H, Black MM (2006) The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol 54:395–404
7. Ameglio F, D'Auria L, Bonifati C, Ferraro C, Mastroianni A, Giacalone B (1998) Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity. Br J Dermatol 138:611–614
8. Andra K, Lassmann H, Bittner R, Shorny S, Fassler R, Propst F, Wiche G (1997) Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev 11:3143–3156
9. Aumailley M (2013) The laminin family. Cell Adhes Migr 7:48–55
10. Baden LA, Apovian C, Imber MJ, Dover JS (1988) Vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol 124:1186–1188
11. Bakker CV, Terra JB, Jonkman MF (2014) Toward a practical renaming of bullous pemphigoid and all its variants—reply. JAMA Dermatol 150:459–460
12. Balding SD, Prost C, Diaz LA, Bernard P, Bedane C, Aberdam D, Giudice GJ (1996) Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 106:141–146
13. Barzegar M, Mozafari N, Kariminejad A, Asadikani Z, Ozoemena L, McGrath JA (2013) A new homozygous nonsense mutation in LAMA3A underlying laryngo-onycho-cutaneous syndrome. Br J Dermatol 169:1353–1356
14. Bedane C, McMillan JR, Balding SD, Bernard P, Prost C, Bonnetblanc JM, Diaz LA, Eady RA, Giudice GJ (1997) Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol 108:901–907
15. Behrens DT, Villone D, Koch M, Brunner G, Sorokin L, Robenek H, Bruckner-Tuderman L, Bruckner P, Hansen U (2012) The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens. J Biol Chem 287:18700–18709
16. Bentz H, Morris NP, Murray LW, Sakai LY, Hollister DW, Burgeson RE (1983) Isolation and partial characterization of a new human collagen with an extended triple-helical structural domain. Proc Natl Acad Sci U S A 80:3168–3172
17. Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP, Lorette G, Bonnetblanc JM, Prost C (1995) Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 131:48–52
18. Bernard P, Antonicelli F, Bedane C, Joly P, Le Roux-Villet C, Duvert-Lehembre S, Rousselle P, Prost-Squarcioni C (2013) Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid. JAMA Dermatol 149:533–540
19. Bertram F, Brocker EB, Zillikens D, Schmidt E (2009) Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 7:434–440
20. Bhol KC, Goss L, Kumari S, Colon JE, Ahmed AR (2001) Autoantibodies to human alpha6 integrin in patients with oral pemphigoid. J Dent Res 80:1711–1715
21. Bolling MC, Pas HH, de Visser M, Aronica E, Pfendner EG, van den Berg MP, Diercks GF, Suurmeijer AJ, Jonkman MF (2010) PLEC1 mutations underlie adult-onset dilated cardiomyopathy in epidermolysis bullosa simplex with muscular dystrophy. J Invest Dermatol 130:1178–1181
22. Bolling MC, Lemmink HH, Jansen GH, Jonkman MF (2011) Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75 % of the patients. Br J Dermatol 164:637–644
23. Bolling MC, Jongbloed JD, Boven LG, Diercks GF, Smith FJ, McLean WH, Jonkman MF (2014) Plectin mutations underlie epidermolysis bullosa simplex in 8 % of patients. J Invest Dermatol 134:273–276
24. Borradori L, Sonnenberg A (1996) Hemidesmosomes: roles in adhesion, signaling and human diseases. Curr Opin Cell Biol 8:647–656
25. Borradori L, Sonnenberg A (1999) Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 112:411–418
26. Borradori L, Koch PJ, Niessen CM, Erkeland S, van Leusden MR, Sonnenberg A (1997) The localization of bullous pemphigoid antigen 180 (BP180) in hemidesmosomes is mediated by its cytoplasmic domain and seems to be regulated by the beta4 integrin subunit. J Cell Biol 136:1333–1347
27. Borradori L, Chavanas S, Schaapveld RQ, Gagnoux-Palacios L, Calafat J, Meneguzzi G, Sonnenberg A (1998) Role of the bullous pemphigoid antigen 180 (BP180) in the assembly of hemidesmosomes and cell adhesion–reexpression of BP180 in generalized atrophic benign epidermolysis bullosa keratinocytes. Exp Cell Res 239:463–476
28. Brick KE, Weaver CH, Savica R, Lohse CM, Pittelkow MR, Boeve BF, Gibson LE, Camilleri MJ, Wieland CN (2014) A population-based study of the association between bullous pemphigoid and neurologic disorders. J Am Acad Dermatol (in press)
29. Brown A, Bernier G, Mathieu M, Rossant J, Kothary R (1995) The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nat Genet 10:301–306
30. Brown TA, Gil SG, Sybert VP, Lestringant GG, Tadini G, Caputo R, Carter WG (1996) Defective integrin alpha 6 beta 4 expression in the skin of patients with junctional epidermolysis bullosa and pyloric atresia. J Invest Dermatol 107:384–391
31. Brunsting LA, Perry HO (1957) Benign pemphigoid; a report of seven cases with chronic, scarring, herpetiform plaques about the head and neck. AMA Arch Dermatol 75:489–501
32. Buijsrogge JJ, de Jong MC, Kloosterhuis GJ, Vermeer MH, Koster J, Sonnenberg A, Jonkman MF, Pas HH (2009) Antiplectin autoantibodies in subepidermal blistering diseases. Br J Dermatol 161:762–771
33. Buijsrogge JJ, Diercks GF, Pas HH, Jonkman MF (2011) The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy. Br J Dermatol 165:92–98
34. Burge S, Wojnarowska F, Marsden A (1988) Chronic bullous dermatosis of childhood persisting into adulthood. Pediatr Dermatol 5:246–249
35. Camilleri M, Pace JL (1998) Drug-induced linear immunoglobulin-A bullous dermatosis. Clin Dermatol 16:389–391
36. Caproni M, Rolfo S, Bernacchi E, Bianchi B, Brazzini B, Fabbri P (1999) The role of lymphocytes, granulocytes, mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis. Br J Dermatol 140:1072–1078
37. Chan LS (2012) Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid). Clin Dermatol 30:34–37
38. Chan LS, Fine JD, Briggaman RA, Woodley DT, Hammerberg C, Drugge RJ, Cooper KD (1993) Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease. J Invest Dermatol 101:262–267
39. Chan LS, Majmudar AA, Tran HH, Meier F, Schaumburg-Lever G, Chen M, Anhalt G, Woodley DT, Marinkovich MP (1997) Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J Invest Dermatol 108:848–853
40. Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM, Wojnarowska F, Stevens SR, Chen M, Fairley JA, Woodley DT, Miller SD, Gordon KB (1998) Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 110:103–109
41. Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, Fine JD, Foster CS, Ghohestani R, Hashimoto T, Hoang-Xuan T, Kirtschig G, Korman NJ, Lightman S, Lozada-Nur F, Marinkovich MP, Mondino BJ, Prost-Squarcioni C, Rogers RS 3rd, Setterfield JF, West DP, Wojnarowska F, Woodley DT, Yancey KB, Zillikens D, Zone JJ (2002) The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 138:370–379
42. Chan RY, Bhol K, Tesavibul N, Letko E, Simmons RK, Foster CS, Ahmed AR (1999) The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 40:2283–2290
43. Charlesworth A, Chiaverini C, Chevrant-Breton J, DelRio M, Diociaiuti A, Dupuis RP, El Hachem M, Le Fiblec B, Sankari-Ho AM, Valhquist A, Wierzbicka E, Lacour JP, Meneguzzi G (2013) Epidermolysis bullosa simplex with PLEC mutations: new phenotypes and new mutations. Br J Dermatol 168:808–814
44. Chen KR, Shimizu S, Miyakawa S, Ishiko A, Shimizu H, Hashimoto T (1996) Coexistence of psoriasis and an unusual IgG-mediated subepidermal bullous dermatosis: identification of a novel 200-kDa lower lamina lucida target antigen. Br J Dermatol 134:340–346
45. Chen M, O'Toole EA, Sanghavi J, Mahmud N, Kelleher D, Weir D, Fairley JA, Woodley DT (2002) The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn’s disease have autoantibodies to type VII collagen. J Invest Dermatol 118:1059–1064
46. Chen M, Doostan A, Bandyopadhyay P, Remington J, Wang X, Hou Y, Liu Z, Woodley DT (2007) The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. Am J Pathol 170:2009–2018
47. Chen M, Kim GH, Prakash L, Woodley DT (2012) Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen. Autoimmunity 45:91–101
48. Christiano AM, Uitto J (1996) Molecular complexity of the cutaneous basement membrane zone. Exp Dermatol 5:1–11
49. Christiano AM, Hoffman GG, Chung-Honet LC, Lee S, Cheng W, Uitto J, Greenspan DS (1994) Structural organization of the human type VII collagen gene (COL7A1), composed of more exons than any previously characterized gene. Genomics 21:169–179
50. Chung HJ, Uitto J (2010) Epidermolysis bullosa with pyloric atresia. Dermatol Clin 28:43–54
51. Cohen DM, Ben-Amitai D, Feinmesser M, Zvulunov A (2009) Childhood lichen planus pemphigoides: a case report and review of the literature. Pediatr Dermatol 26:569–574
52. Collier PM, Wojnarowska F, Welsh K, McGuire W, Black MM (1999) Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression. Br J Dermatol 141:867–875
53. Corden LD, McLean WH (1996) Human keratin diseases: hereditary fragility of specific epithelial tissues. Exp Dermatol 5:297–307
54. Cortes B, Marazza G, Naldi L, Combescure C, Borradori L, Autoimmune Bullous Disease Swiss Study Group (2011) Mortality of bullous pemphigoid in Switzerland: a prospective study. Br J Dermatol 165:368–374
55. Coulombe PA, Hutton ME, Vassar R, Fuchs E (1991) A function for keratins and a common thread among different types of epidermolysis bullosa simplex diseases. J Cell Biol 115:1661–1674
56. Culton DA, Diaz LA (2012) Treatment of subepidermal immunobullous diseases. Clin Dermatol 30:95–102
57. Dainichi T, Kurono S, Ohyama B, Ishii N, Sanzen N, Hayashi M, Shimono C, Taniguchi Y, Koga H, Karashima T, Yasumoto S, Zillikens D, Sekiguchi K, Hashimoto T (2009) Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci U S A 106:2800–2805
58. Dainichi T, Koga H, Tsuji T, Ishii N, Ohyama B, Ueda A, Natsuaki Y, Karashima T, Nakama T, Yasumoto S, Zillikens D, Hashimoto T (2010) From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid. J Dermatol 37:231–238
59. Daito J, Katoh N, Asai J, Ueda E, Takenaka H, Ishii N, Hashimoto T, Kishimoto S (2008) Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180. Br J Dermatol 159:984–986
60. D'Auria L, Bonifati C, Cordiali-Fei P, Leone G, Picardo M, Pietravalle M, Giacalone B, Ameglio F (1999) Increased serum interleukin-15 levels in bullous skin diseases: correlation with disease intensity. Arch Dermatol Res 291:354–356
61. de Pereda JM, Lillo MP, Sonnenberg A (2009) Structural basis of the interaction between integrin alpha6beta4 and plectin at the hemidesmosomes. EMBO J 28:1180–1190
62. Delgado JC, Turbay D, Yunis EJ, Yunis JJ, Morton ED, Bhol K, Norman R, Alper CA, Good RA, Ahmed R (1996) A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci U S A 93:8569–8571
63. Di Zenzo G, Della Torre R, Zambruno G, Borradori L (2012) Bullous pemphigoid: from the clinic to the bench. Clin Dermatol 30:3–16
64. Dilling A, Rose C, Hashimoto T, Zillikens D, Shimanovich I (2007) Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease. J Dermatol 34:1–8
65. DiPersio CM, Hodivala-Dilke KM, Jaenisch R, Kreidberg JA, Hynes RO (1997) Alpha3beta1 integrin is required for normal development of the epidermal basement membrane. J Cell Biol 137:729–742
66. Djahansouzi S, Nestle-Kraemling C, Dall P, Bender HG, Hanstein B (2003) Herpes gestationis may present itself as a paraneoplastic syndrome of choriocarcinoma—a case report. Gynecol Oncol 89:334–337
67. Domloge-Hultsch N, Gammon WR, Briggaman RA, Gil SG, Carter WG, Yancey KB (1992) Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 90:1628–1633
68. Domloge-Hultsch N, Anhalt GJ, Gammon WR, Lazarova Z, Briggaman R, Welch M, Jabs DA, Huff C, Yancey KB (1994) Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder. Arch Dermatol 130:1521–1529
69. Durbeej M (2010) Laminins. Cell Tissue Res 339:259–268
70. Egan CA, Yancey KB (2000) The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease. Eur J Dermatol 10:585–589
71. Egan CA, Lazarova Z, Darling TN, Yee C, Cote T, Yancey KB (2001) Anti-epiligrin cicatricial pemphigoid and relative risk for cancer. Lancet 357:1850–1851
72. Egan CA, Lazarova Z, Darling TN, Yee C, Yancey KB (2003) Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations. Medicine (Baltimore) 82:177–186
73. Fairley JA, Heintz PW, Neuburg M, Diaz LA, Giudice GJ (1995) Expression pattern of the bullous pemphigoid-180 antigen in normal and neoplastic epithelia. Br J Dermatol 133:385–391
74. Fine JD, Mellerio JE (2009) Extracutaneous manifestations and complications of inherited epidermolysis bullosa. Part II. Other organs. J Am Acad Dermatol 61:387–402
75. Fine JD, Johnson LB, Weiner M, Stein A, Cash S, Deleoz J, Devries DT, Suchindran C (2005) Pseudosyndactyly and musculoskeletal contractures in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry, 1986–2002. J Hand Surg (Br) 30:14–22
76. Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L, Heagerty A, Hintner H, Hovnanian A, Jonkman MF, Leigh I, McGrath JA, Mellerio JE, Murrell DF, Shimizu H, Uitto J, Vahlquist A, Woodley D, Zambruno G (2008) The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 58:931–950
77. Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C (2009) Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986–2006. J Am Acad Dermatol 60:203–211
78. Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Bauer JW, Has C, Heagerty A, Hintner H, Hovnanian A, Jonkman MF, Leigh I, Marinkovich MP, Martinez AE, McGrath JA, Mellerio JE, Moss C, Murrell DF, Shimizu H, Uitto J, Woodley D, Zambruno G (2014) Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 70:1103-1126
79. Foisner R, Feldman B, Sander L, Wiche G (1991) Monoclonal antibody mapping of structural and functional plectin epitopes. J Cell Biol 112:397–405
80. Fortuna G, Marinkovich MP (2012) Linear immunoglobulin A bullous dermatosis. Clin Dermatol 30:38–50
81. Fortuna G, Salas-Alanis JC, Guidetti E, Marinkovich MP (2012) A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: a real and separate nosological entity? J Am Acad Dermatol 66:988–994
82. Foster CS, Chang PY, Ahmed AR (2010) Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report. Ophthalmology 117:861–869
83. Frew JW, Martin LK, Nijsten T, Murrell DF (2009) Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument. Br J Dermatol 161:1323–1330
84. Fuchs E (1996) The cytoskeleton and disease: genetic disorders of intermediate filaments. Annu Rev Genet 30:197–231
85. Fuchs E, Cleveland DW (1998) A structural scaffolding of intermediate filaments in health and disease. Science 279:514–519
86. Fukuda S, Tsuruta D, Uchiyama M, Mitsuhashi Y, Kobayashi H, Ishikawa T, Ohyama B, Ishii N, Hamada T, Dainichi T, Karashima T, Nakama T, Yasumoto S, Hashimoto T (2011) Brunsting-Perry type pemphigoid with IgG autoantibodies to laminin-332, BP230 and desmoplakins I/II. Br J Dermatol 165:433–435
87. Gache Y, Allegra M, Bodemer C, Pisani-Spadafora A, de Prost Y, Ortonne JP, Meneguzzi G (2001) Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with aging. Hum Mol Genet 10:2453–2461
88. Gammon WR, Heise ER, Burke WA, Fine JD, Woodley DT, Briggaman RA (1988) Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol 91:228–232
89. Garcia-Martin P, Fraga J, Hashimoto T, Garcia-Diez A (2014) Brunsting-Perry-type cicatricial pemphigoid with IgG autoantibodies to LAD-1. Br J Dermatol 170:743–745
90. Ghohestani RF, Nicolas JF, Kanitakis J, Claudy A (1997) Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens. J Invest Dermatol 108:854–858
91. Gibson V, Tschen JA, Bean SF (1986) Localized cicatricial pemphigoid (Brunsting-Perry syndrome). Cutis 38:252–253
92. Giorda R, Cerritello A, Bonaglia MC, Bova S, Lanzi G, Repetti E, Giglio S, Baschirotto C, Pramparo T, Avolio L, Bragheri R, Maraschio P, Zuffardi O (2004) Selective disruption of muscle and brain-specific BPAG1 isoforms in a girl with a 6;15 translocation, cognitive and motor delay, and tracheo-oesophageal atresia. J Med Genet 41:e71
93. Giudice GJ, Emery DJ, Diaz LA (1992) Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 99:243–250
94. Goletz S, Hashimoto T, Zillikens D, Schmidt E (2014) Anti-p200 pemphigoid. J Am Acad Dermatol 71:185–191
95. Gostynski A, Pasmooij AM, Jonkman MF (2014) Successful therapeutic transplantation of revertant skin in epidermolysis bullosa. J Am Acad Dermatol 70:98–101
96. Green KJ, Jones JC (1996) Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J 10:871–881
97. Groth S, Recke A, Vafia K, Ludwig RJ, Hashimoto T, Zillikens D, Schmidt E (2011) Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid. Br J Dermatol 164:76–82
98. Groves RW, Liu L, Dopping-Hepenstal PJ, Markus HS, Lovell PA, Ozoemena L, Lai-Cheong JE, Gawler J, Owaribe K, Hashimoto T, Mellerio JE, Mee JB, McGrath JA (2010) A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Dermatol 130:1551–1557
99. Gu LH, Xu TS, Huang W, Xie M, Shi WB, Sun SD, Hou SS (2013) Developmental characteristics of pectoralis muscle in Pekin duck embryos. Genet Mol Res 12:6733–6742
100. Guide SV, Marinkovich MP (2001) Linear IgA bullous dermatosis. Clin Dermatol 19:719–727
101. Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345–357
102. Gunther C, Carballido-Perrig N, Kopp T, Carballido JM, Pfeiffer C (2009) CCL18 is expressed in patients with bullous pemphigoid and parallels disease course. Br J Dermatol 160:747–755
103. Guo L, Degenstein L, Dowling J, Yu QC, Wollmann R, Perman B, Fuchs E (1995) Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 81:233–243
104. Has C, Castiglia D, del Rio M, Diez MG, Piccinni E, Kiritsi D, Kohlhase J, Itin P, Martin L, Fischer J, Zambruno G, Bruckner-Tuderman L (2011) Kindler syndrome: extension of FERMT1 mutational spectrum and natural history. Hum Mutat 32:1204–1212
105. Has C, Sparta G, Kiritsi D, Weibel L, Moeller A, Vega-Warner V, Waters A, He Y, Anikster Y, Esser P, Straub BK, Hausser I, Bockenhauer D, Dekel B, Hildebrandt F, Bruckner-Tuderman L, Laube GF (2012) Integrin alpha3 mutations with kidney, lung, and skin disease. N Engl J Med 366:1508–1514
106. Has C, Kiritsi D, Mellerio JE, Franzke CW, Wedgeworth E, Tantcheva-Poor I, Kernland-Lang K, Itin P, Simpson MA, Dopping-Hepenstal PJ, Fujimoto W, McGrath JA, Bruckner-Tuderman L (2014) The missense mutation p.R1303Q in type XVII collagen underlies junctional epidermolysis bullosa resembling Kindler syndrome. J Invest Dermatol 134:845–849
107. Herrmann H, Strelkov SV, Burkhard P, Aebi U (2009) Intermediate filaments: primary determinants of cell architecture and plasticity. J Clin Invest 119:1772–1783
108. Hintner H, Wolff K (1982) Generalized atrophic benign epidermolysis bullosa. Arch Dermatol 118:375–384
109. Hirako Y, Usukura J, Uematsu J, Hashimoto T, Kitajima Y, Owaribe K (1998) Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide. J Biol Chem 273:9711–9717
110. Holmes RC, Black MM, Dann J, James DC, Bhogal B (1982) A comparative study of toxic erythema of pregnancy and herpes gestationis. Br J Dermatol 106:499–510
111. Holmes RC, Black MM, Jurecka W, Dann J, James DC, Timlin D, Bhogal B (1983) Clues to the aetiology and pathogenesis of herpes gestationis. Br J Dermatol 109:131–139
112. Hopkinson SB, Riddelle KS, Jones JC (1992) Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization. J Invest Dermatol 99:264–270
113. Horvath B, Niedermeier A, Podstawa E, Muller R, Hunzelmann N, Karpati S, Hertl M (2010) IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis. Exp Dermatol 19:648–653
114. Hovnanian A, Pollack E, Hilal L, Rochat A, Prost C, Barrandon Y, Goossens M (1993) A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex. Nat Genet 3:327–332
115. Huber M, Floeth M, Borradori L, Schacke H, Rugg EL, Lane EB, Frenk E, Hohl D, Bruckner-Tuderman L (2002) Deletion of the cytoplasmatic domain of BP180/collagen XVII causes a phenotype with predominant features of epidermolysis bullosa simplex. J Invest Dermatol 118:185–192
116. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110:673–687
117. Inoue M, Tamai K, Shimizu H, Owaribe K, Nakama T, Hashimoto T, McGrath JA (2000) A homozygous missense mutation in the cytoplasmic tail of beta4 integrin, G931D, that disrupts hemidesmosome assembly and underlies non-Herlitz junctional epidermolysis bullosa without pyloric atresia? J Invest Dermatol 114:1061–1064
118. Intong LR, Murrell DF (2011) Pemphigoid gestationis: pathogenesis and clinical features. Dermatol Clin 29:447–452
119. Intong LR, Murrell DF (2012) Inherited epidermolysis bullosa: new diagnostic criteria and classification. Clin Dermatol 30:70–77
120. Ishii N, Yoshida M, Hisamatsu Y, Ishida-Yamamoto A, Nakane H, Iizuka H, Tanaka T, Hashimoto T (2004) Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br J Dermatol 150:843–851
121. Ishii N, Yoshida M, Ishida-Yamamoto A, Fritsch A, Elfert S, Bruckner-Tuderman L, Hashimoto T (2009) Some epidermolysis bullosa acquisita sera react with epitopes within the triple-helical collagenous domain as indicated by immunoelectron microscopy. Br J Dermatol 160:1090–1093
122. Jedlickova H, Niedermeier A, Zgazarova S, Hertl M (2011) Brunsting-Perry pemphigoid of the scalp with antibodies against laminin 332. Dermatology 222:193–195
123. Jenkins RE, Jones SA, Black MM (1996) Conversion of pemphigoid gestationis to bullous pemphigoid—two refractory cases highlighting this association. Br J Dermatol 135:595–598
124. Joly P, Baricault S, Sparsa A, Bernard P, Bedane C, Duvert-Lehembre S, Courville P, Bravard P, Remond B, Doffoel-Hantz V, Benichou J (2012) Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol 132:1998–2004
125. Jones J, Downer CS, Speight PM (1995) Changes in the expression of integrins and basement membrane proteins in benign mucous membrane pemphigoid. Oral Dis 1:159–165
126. Jones JC, Hopkinson SB, Goldfinger LE (1998) Structure and assembly of hemidesmosomes. Bioessays 20:488–494
127. Jonkman MF, Pasmooij AM (2009) Revertant mosaicism–patchwork in the skin. N Engl J Med 360:1680–1682
128. Jonkman MF, de Jong MC, Heeres K, Pas HH, van der Meer JB, Owaribe K, Martinez de Velasco AM, Niessen CM, Sonnenberg A (1995) 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest 95:1345–1352
129. Jonkman MF, Heeres K, Pas HH, van Luyn MJ, Elema JD, Corden LD, Smith FJ, McLean WH, Ramaekers FC, Burton M, Scheffer H (1996) Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex. J Invest Dermatol 107:764–769
130. Jonkman MF, Scheffer H, Stulp R, Pas HH, Nijenhuis M, Heeres K, Owaribe K, Pulkkinen L, Uitto J (1997) Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell 88:543–551
131. Jonkman MF, Pas HH, Nijenhuis M, Kloosterhuis G, Steege G (2002) Deletion of a cytoplasmic domain of integrin beta4 causes epidermolysis bullosa simplex. J Invest Dermatol 119:1275–1281
132. Karakose E, Schiller HB, Fassler R (2010) The kindlins at a glance. J Cell Sci 123:2353–2356
133. Karamatic Crew V, Burton N, Kagan A, Green CA, Levene C, Flinter F, Brady RL, Daniels G, Anstee DJ (2004) CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood 104:2217–2223
134. Kasperkiewicz M, Zillikens D, Schmidt E (2012) Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity 45:55–70
135. Kelly SE, Frith PA, Millard PR, Wojnarowska F, Black MM (1988) A clinicopathological study of mucosal involvement in linear IgA disease. Br J Dermatol 119:161–170
136. Kelly SE, Bhogal BS, Wojnarowska F, Whitehead P, Leigh IM, Black MM (1990) Western blot analysis of the antigen in pemphigoid gestationis. Br J Dermatol 122:445–449
137. Kim JH, Kim SC (2013) Epidermolysis bullosa acquisita. J Eur Acad Dermatol Venereol 27:1204–1213
138. Kim JH, Kim YH, Kim S, Noh EB, Kim SE, Vorobyev A, Schmidt E, Zillikens D, Kim SC (2013) Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions. J Eur Acad Dermatol Venereol 27:e224–e230
139. Kindler T (1954) Congenital poikiloderma with traumatic bulla formation and progressive cutaneous atrophy. Br J Dermatol 66:104–111
140. Kiritsi D, Kern JS, Schumann H, Kohlhase J, Has C, Bruckner-Tuderman L (2011) Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa. J Med Genet 48:450–457
141. Kiritsi D, Has C, Bruckner-Tuderman L (2013a) Laminin 332 in junctional epidermolysis bullosa. Cell Adhes Migr 7:135–141
142. Kiritsi D, Pigors M, Tantcheva-Poor I, Wessel C, Arin MJ, Kohlhase J, Bruckner-Tuderman L, Has C (2013b) Epidermolysis bullosa simplex ogna revisited. J Invest Dermatol 133:270–273
143. Kirtschig G, Marinkovich MP, Burgeson RE, Yancey KB (1995) Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. J Invest Dermatol 105:543–548
144. Kirtschig G, Middleton P, Bennett C, Murrell DF, Wojnarowska F, Khumalo NP (2010) Interventions for bullous pemphigoid. Cochrane Database Syst Rev 10:CD002292
145. Kiss M, Perenyi A, Marczinovits I, Molnar J, Dobozy A, Kemeny L, Husz S (2005) Autoantibodies to human alpha6 integrin in patients with bullous pemphigoid. Ann N Y Acad Sci 1051:104–110
146. Kneisel A, Hertl M (2011) Autoimmune bullous skin diseases. Part 1. Clinical manifestations. J Dtsch Dermatol Ges 9:844–856
147. Koga H, Ishii N, Dainichi T, Tsuruta D, Hamada T, Ohata C, Karashima T, Furumura M, Hashimoto T (2013) An attempt to develop mouse model for anti-laminin gamma1 pemphigoid. J Dermatol Sci 70:108–115
148. Koster J, Geerts D, Favre B, Borradori L, Sonnenberg A (2003) Analysis of the interactions between BP180, BP230, plectin and the integrin alpha6beta4 important for hemidesmosome assembly. J Cell Sci 116:387–399
149. Koster J, van Wilpe S, Kuikman I, Litjens SH, Sonnenberg A (2004) Role of binding of plectin to the integrin beta4 subunit in the assembly of hemidesmosomes. Mol Biol Cell 15:1211–1223
150. Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, Jones RC, Jaenisch R (1996) Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 122:3537–3547
151. Kromminga A, Sitaru C, Meyer J, Arndt R, Schmidt E, Christophers E, Brocker EB, Zillikens D (2002) Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain. J Dermatol Sci 28:68–75
152. Kurpakus MA, Jones JC (1991) A novel hemidesmosomal plaque component: tissue distribution and incorporation into assembling hemidesmosomes in an in vitro model. Exp Cell Res 194:139–146
153. Kurzhals G, Stolz W, Meurer M, Kunze J, Braun-Falco O, Krieg T (1991) Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. Arch Dermatol 127:391–395
154. Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA (1986) Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 136:1231–1235
155. Laffitte E, Favre B, Fontao L, Riou S, Jaunin F, Tamm K, Saurat JH, Borradori L (2001) Plectin, an unusual target antigen in bullous pemphigoid. Br J Dermatol 144:136–138
156. Lai-Cheong JE, McGrath JA (2010) Kindler syndrome. Dermatol Clin 28:119–124
157. Lai-Cheong JE, Moss C, Parsons M, Almaani N, McGrath JA (2012) Revertant mosaicism in Kindler syndrome. J Invest Dermatol 132:730–732
158. Laimer M, Lanschuetzer CM, Diem A, Bauer JW (2010) Herlitz junctional epidermolysis bullosa. Dermatol Clin 28:55–60
159. Langan SM, Groves RW, West J (2011) The relationship between neurological disease and bullous pemphigoid: a population-based case–control study. J Invest Dermatol 131:631–636
160. Lapiere JC, Woodley DT, Parente MG, Iwasaki T, Wynn KC, Christiano AM, Uitto J (1993) Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 92:1831–1839
161. Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB (1996) Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest 98:1509–1518
162. Lazarova Z, Hsu R, Yee C, Yancey KB (2000) Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model. J Invest Dermatol 114:178–184
163. Lazarova Z, Yee C, Lazar J, Yancey KB (2001) IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5 alpha-subunit. Clin Immunol 101:100–105
164. Lazarova Z, Sitaru C, Zillikens D, Yancey KB (2004) Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid. J Am Acad Dermatol 51:886–892
165. Lazor JB, Varvares MA, Montgomery WW, Goodman ML, Mackool BT (1996) Management of airway obstruction in cicatricial pemphigoid. Laryngoscope 106:1014–1017
166. Lee CW, Kim SC, Han H (1996) Distribution of HLA class II alleles in Korean patients with epidermolysis bullosa acquisita. Dermatology 193:328–329
167. Letko E, Bhol K, Foster SC, Ahmed RA (2000) Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study. Curr Eye Res 21:646–654
168. Leung CL, Zheng M, Prater SM, Liem RK (2001) The BPAG1 locus: alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles. J Cell Biol 154:691–697
169. Leung CL, Green KJ, Liem RK (2002) Plakins: a family of versatile cytolinker proteins. Trends Cell Biol 12:37–45
170. Leverkus M, Bhol K, Hirako Y, Pas H, Sitaru C, Baier G, Brocker EB, Jonkman MF, Ahmed AR, Zillikens D (2001) Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230. Br J Dermatol 145:998–1004
171. Lin MS, Gharia M, Fu CL, Olague-Marchan M, Hacker M, Harman KE, Bhogal BS, Black MM, Diaz LA, Giudice GJ (1999) Molecular mapping of the major epitopes of BP180 recognized by herpes gestationis autoantibodies. Clin Immunol 92:285–292
172. Liu CG, Maercker C, Castanon MJ, Hauptmann R, Wiche G (1996) Human plectin: organization of the gene, sequence analysis, and chromosome localization (8q24). Proc Natl Acad Sci U S A 93:4278–4283
173. Liu L, Dopping-Hepenstal PJ, Lovell PA, Michael M, Horn H, Fong K, Lai-Cheong JE, Mellerio JE, Parsons M, McGrath JA (2012) Autosomal recessive epidermolysis bullosa simplex due to loss of BPAG1-e expression. J Invest Dermatol 132:742–744
174. Liu Z, Zhou X, Shapiro SD, Shipley JM, Twining SS, Diaz LA, Senior RM, Werb Z (2000) The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 102:647–655
175. Lohi J (2001) Laminin-5 in the progression of carcinomas. Int J Cancer 94:763–767
176. Marazza G, Pham HC, Scharer L, Pedrazzetti PP, Hunziker T, Trueb RM, Hohl D, Itin P, Lautenschlager S, Naldi L, Borradori L, Autoimmune Bullous Disease Swiss Study Group (2009) Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol 161:861–868
177. Marinkovich MP (2007) Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nat Rev Cancer 7:370–380
178. Marren P, Wojnarowska F, Venning V, Wilson C, Nayar M (1993) Vulvar involvement in autoimmune bullous diseases. J Reprod Med 38:101–107
179. Martin JM, Pinazo I, Molina I, Monteagudo C, Villalon G, Reig I, Jorda E (2009) Cicatricial pemphigoid of the Brunsting-Perry type. Int J Dermatol 48:293–294
180. Mayne R, Brewton RG (1993) New members of the collagen superfamily. Curr Opin Cell Biol 5:883–890
181. McGrath JA, Gatalica B, Christiano AM, Li K, Owaribe K, McMillan JR, Eady RA, Uitto J (1995) Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet 11:83–86
182. McLean WH, Irvine AD, Hamill KJ, Whittock NV, Coleman-Campbell CM, Mellerio JE, Ashton GS, Dopping-Hepenstal PJ, Eady RA, Jamil T, Phillips R, Shabbir SG, Haroon TS, Khurshid K, Moore JE, Page B, Darling J, Atherton DJ, Van Steensel MA, Munro CS, Smith FJ, McGrath JA (2003) An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome. Hum Mol Genet 12:2395–2409
183. Messmer EM, Hintschich CR, Partscht K, Messer G, Kampik A (2000) Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications. Ophthalmologe 97:113–120
184. Michel B, Bean SF, Chorzelski T, Fedele CF (1977) Cicatricial pemphigoid of Brunsting-Perry. Immunofluorescent studies. Arch Dermatol 113:1403–1405
185. Miserocchi E, Baltatzis S, Roque MR, Ahmed AR, Foster CS (2002) The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid. Ophthalmology 109:111–118
186. Mitsuya J, Hara H, Ito K, Ishii N, Hashimoto T, Terui T (2008) Metastatic ovarian carcinoma-associated subepidermal blistering disease with autoantibodies to both the p200 dermal antigen and the gamma 2 subunit of laminin 5 showing unusual clinical features. Br J Dermatol 158:1354–1357
187. Mobini N, Nagarwalla N, Ahmed AR (1998) Oral pemphigoid. Subset of cicatricial pemphigoid? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:37–43
188. Morrison LH, Anhalt GJ (1991) Herpes gestationis. J Autoimmun 4:37–45
189. Muller FB, Kuster W, Wodecki K, Almeida H Jr, Bruckner-Tuderman L, Krieg T, Korge BP, Arin MJ (2006) Novel and recurrent mutations in keratin KRT5 and KRT14 genes in epidermolysis bullosa simplex: implications for disease phenotype and keratin filament assembly. Hum Mutat 27:719–720
190. Murakami H, Nishioka S, Setterfield J, Bhogal BS, Black MM, Zillikens D, Yancey KB, Balding SD, Giudice GJ, Diaz LA, Nishikawa T, Kiyokawa C, Hashimoto T (1998) Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid. J Dermatol Sci 17:39–44
191. Murrell DF, Pasmooij AM, Pas HH, Marr P, Klingberg S, Pfendner E, Uitto J, Sadowski S, Collins F, Widmer R, Jonkman MF (2007) Retrospective diagnosis of fatal BP180-deficient non-Herlitz junctional epidermolysis bullosa suggested by immunofluorescence (IF) antigen-mapping of parental carriers bearing enamel defects. J Invest Dermatol 127:1772–1775
192. Murrell DF, Daniel BS, Joly P, Borradori L, Amagai M, Hashimoto T, Caux F, Marinovic B, Sinha AA, Hertl M, Bernard P, Sirois D, Cianchini G, Fairley JA, Jonkman MF, Pandya AG, Rubenstein D, Zillikens D, Payne AS, Woodley D, Zambruno G, Aoki V, Pincelli C, Diaz L, Hall RP, Meurer M, Mascaro JM Jr, Schmidt E, Shimizu H, Zone J, Swerlick R, Mimouni D, Culton D, Lipozencic J, Bince B, Grando SA, Bystryn JC, Werth VP (2012) Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol 66:479–485
193. Nakano A, Pulkkinen L, Murrell D, Rico J, Lucky AW, Garzon M, Stevens CA, Robertson S, Pfendner E, Uitto J (2001) Epidermolysis bullosa with congenital pyloric atresia: novel mutations in the beta 4 integrin gene (ITGB4) and genotype/phenotype correlations. Pediatr Res 49:618–626
194. Nakano A, Chao SC, Pulkkinen L, Murrell D, Bruckner-Tuderman L, Pfendner E, Uitto J (2002) Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes. Hum Genet 110:41–51
195. Ng SY, Venning VV (2011) Management of linear IgA disease. Dermatol Clin 29:629–630
196. Nieboer C, Boorsma DM, Woerdeman MJ, Kalsbeek GL (1980) Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. Br J Dermatol 102:383–392
197. Niessen CM, Hogervorst F, Jaspars LH, de Melker AA, Delwel GO, Hulsman EH, Kuikman I, Sonnenberg A (1994) The alpha 6 beta 4 integrin is a receptor for both laminin and kalinin. Exp Cell Res 211:360–367
198. Niessen CM, van der Raaij-Helmer MH, Hulsman EH, van der Neut R, Jonkman MF, Sonnenberg A (1996) Deficiency of the integrin beta 4 subunit in junctional epidermolysis bullosa with pyloric atresia: consequences for hemidesmosome formation and adhesion properties. J Cell Sci 109:1695–1706
199. Nikolskaia OV, Nousari CH, Anhalt GJ (2003) Paraneoplastic pemphigus in association with Castleman’s disease. Br J Dermatol 149:1143–1151
200. Noe MH, Messingham KA, Brandt DS, Andrews JI, Fairley JA (2010) Pregnant women have increased incidence of IgE autoantibodies reactive with the skin and placental antigen BP180 (type XVII collagen). J Reprod Immunol 85:198–204
201. Omary MB, Coulombe PA, McLean WH (2004) Intermediate filament proteins and their associated diseases. N Engl J Med 351:2087–2100
202. Oyama N, Setterfield JF, Powell AM, Sakuma-Oyama Y, Albert S, Bhogal BS, Vaughan RW, Kaneko F, Challacombe SJ, Black MM (2006) Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity. Br J Dermatol 154:90–98
203. Pacho F, Zambruno G, Calabresi V, Kiritsi D, Schneider H (2011) Efficiency of translation termination in humans is highly dependent upon nucleotides in the neighbourhood of a (premature) termination codon. J Med Genet 48:640–644
204. Pasmooij AM, van der Steege G, Pas HH, Smitt JH, Nijenhuis AM, Zuiderveen J, Jonkman MF (2004) Features of epidermolysis bullosa simplex due to mutations in the ectodomain of type XVII collagen. Br J Dermatol 151:669–674
205. Pasmooij AM, Pas HH, Deviaene FC, Nijenhuis M, Jonkman MF (2005) Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa. Am J Hum Genet 77:727–740
206. Pasmooij AM, Pas HH, Jansen GH, Lemmink HH, Jonkman MF (2007) Localized and generalized forms of blistering in junctional epidermolysis bullosa due to COL17A1 mutations in the Netherlands. Br J Dermatol 156:861–870
207. Pastar Z, Rados J, Lipozencic J, Dobric I, Marinovic B, Ishii N, Hashimoto T (2007) Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid—how to treat it? Int J Dermatol 46:295–298
208. Perriard J, Jaunin F, Favre B, Budinger L, Hertl M, Saurat JH, Borradori L (1999) IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180. J Invest Dermatol 112:141–147
209. Petruzzi M (2012) Mucous membrane pemphigoid affecting the oral cavity: short review on etiopathogenesis, diagnosis and treatment. Immunopharmacol Immunotoxicol 34:363–367
210. Pierce RA, Griffin GL, Mudd MS, Moxley MA, Longmore WJ, Sanes JR, Miner JH, Senior RM (1998) Expression of laminin alpha3, alpha4, and alpha5 chains by alveolar epithelial cells and fibroblasts. Am J Respir Cell Mol Biol 19:237–244
211. Pool M, Boudreau Lariviere C, Bernier G, Young KG, Kothary R (2005) Genetic alterations at the Bpag1 locus in dt mice and their impact on transcript expression. Mamm Genome 16:909–917
212. Poulter JA, El-Sayed W, Shore RC, Kirkham J, Inglehearn CF, Mighell AJ (2014) Whole-exome sequencing, without prior linkage, identifies a mutation in LAMB3 as a cause of dominant hypoplastic amelogenesis imperfecta. Eur J Hum Genet 22:132–135
213. Proby C, Fujii Y, Owaribe K, Nishikawa T, Amagai M (1999) Human autoantibodies against HD1/plectin in paraneoplastic pemphigus. J Invest Dermatol 112:153–156
214. Pulkkinen L, Kimonis VE, Xu Y, Spanou EN, McLean WH, Uitto J (1997) Homozygous alpha6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum Mol Genet 6:669–674
215. Pulkkinen L, Rouan F, Bruckner-Tuderman L, Wallerstein R, Garzon M, Brown T, Smith L, Carter W, Uitto J (1998) Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense. Am J Hum Genet 63:1376–1387
216. Ray TL, Levine JB, Weiss W, Ward PA (1982) Epidermolysis bullosa acquisita and inflammatory bowel disease. J Am Acad Dermatol 6:242–252
217. Reddy H, Shipman AR, Wojnarowska F (2013) Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature. Clin Exp Dermatol 38:225–229
218. Reed WB, College J Jr, Francis MJ, Zachariae H, Mohs F, Sher MA, Sneddon IB (1974) Epidermolysis bullosa dystrophica with epidermal neoplasms. Arch Dermatol 110:894–902
219. Rezniczek GA, Walko G, Wiche G (2010) Plectin gene defects lead to various forms of epidermolysis bullosa simplex. Dermatol Clin 28:33–41
220. Roenigk HH Jr, Ryan JG, Bergfeld WF (1971) Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol 103:1–10
221. Rognoni E, Widmaier M, Jakobson M, Ruppert R, Ussar S, Katsougkri D, Bottcher RT, Lai-Cheong JE, Rifkin DB, McGrath JA, Fassler R (2014) Kindlin-1 controls Wnt and TGF-beta availability to regulate cutaneous stem cell proliferation. Nat Med 20:350–359
222. Rose C, Weyers W, Denisjuk N, Hillen U, Zillikens D, Shimanovich I (2007) Histopathology of anti-p200 pemphigoid. Am J Dermatopathol 29:119–124
223. Ross AH, Jaycock P, Cook SD, Dick AD, Tole DM (2009) The use of rituximab in refractory mucous membrane pemphigoid with severe ocular involvement. Br J Ophthalmol 93:421–422
224. Rugg EL, McLean WH, Lane EB, Pitera R, McMillan JR, Dopping-Hepenstal PJ, Navsaria HA, Leigh IM, Eady RA (1994) A functional “knockout” of human keratin 14. Genes Dev 8:2563–2573
225. Rugg EL, Horn HM, Smith FJ, Wilson NJ, Hill AJ, Magee GJ, Shemanko CS, Baty DU, Tidman MJ, Lane EB (2007) Epidermolysis bullosa simplex in Scotland caused by a spectrum of keratin mutations. J Invest Dermatol 127:574–580
226. Rzany B, Partscht K, Jung M, Kippes W, Mecking D, Baima B, Prudlo C, Pawelczyk B, Messmer EM, Schuhmann M, Sinkgraven R, Buchner L, Budinger L, Pfeiffer C, Sticherling M, Hertl M, Kaiser HW, Meurer M, Zillikens D, Messer G (2002) Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. Arch Dermatol 138:903–908
227. Sachs N, Kreft M, van den Bergh Weerman MA, Beynon AJ, Peters TA, Weening JJ, Sonnenberg A (2006) Kidney failure in mice lacking the tetraspanin CD151. J Cell Biol 175:33–39
228. Sakai LY, Keene DR, Morris NP, Burgeson RE (1986) Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol 103:1577–1586
229. Sami N, Bhol KC, Ahmed AR (2002) Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human alpha6 integrin. Clin Exp Immunol 129:533–540
230. Saw VP, Dart JK (2008) Ocular mucous membrane pemphigoid: diagnosis and management strategies. Ocul Surf 6:128–142
231. Sawamura D, Li KH, Nomura K, Sugita Y, Christiano AM, Uitto J (1991) Bullous pemphigoid antigen: cDNA cloning, cellular expression, and evidence for polymorphism of the human gene. J Invest Dermatol 96:908–915
232. Schmidt E, Zillikens D (2010) Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev 10:84–89
233. Schmidt E, Zillikens D (2013) Pemphigoid diseases. Lancet 381:320–332
234. Schmidt E, Obe K, Brocker EB, Zillikens D (2000) Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 136:174–178
235. Schmidt E, Meyer-Ter-Vehn T, Zillikens D, Geerling G (2008) Mucous membrane pemphigoid with ocular involvement. Part I. Clinical manifestations, pathogenesis and diagnosis. Ophthalmologe 105:285–297
236. Schneider H, Muhle C, Pacho F (2007) Biological function of laminin-5 and pathogenic impact of its deficiency. Eur J Cell Biol 86:701–717
237. Schuilenga-Hut PH, Scheffer H, Pas HH, Nijenhuis M, Buys CH, Jonkman MF (2002) Partial revertant mosaicism of keratin 14 in a patient with recessive epidermolysis bullosa simplex. J Invest Dermatol 118:626–630
238. Schumann H, Hammami-Hauasli N, Pulkkinen L, Mauviel A, Kuster W, Luthi U, Owaribe K, Uitto J, Bruckner-Tuderman L (1997) Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relation to biological and clinical phenotypes of junctional epidermolysis bullosa. Am J Hum Genet 60:1344–1353
239. Semkova K, Black M (2009) Pemphigoid gestationis: current insights into pathogenesis and treatment. Eur J Obstet Gynecol Reprod Biol 145:138–144
240. Seppanen A, Autio-Harmainen H, Alafuzoff I, Sarkioja T, Veijola J, Hurskainen T, Bruckner-Tuderman L, Tasanen K, Majamaa K (2006) Collagen XVII is expressed in human CNS neurons. Matrix Biol 25:185–188
241. Shimanovich I, Brocker EB, Zillikens D (2002) Pemphigoid gestationis: new insights into the pathogenesis lead to novel diagnostic tools. BJOG 109:970–976
242. Shornick JK, Stastny P, Gilliam JN (1981) High frequency of histocompatibility antigens HLA-DR3 and DR4 in herpes gestations. J Clin Invest 68:553–555
243. Siegel DH, Ashton GH, Penagos HG, Lee JV, Feiler HS, Wilhelmsen KC, South AP, Smith FJ, Prescott AR, Wessagowit V, Oyama N, Akiyama M, Al Aboud D, Al Aboud K, Al Githami A, Al Hawsawi K, Al Ismaily A, Al-Suwaid R, Atherton DJ, Caputo R, Fine JD, Frieden IJ, Fuchs E, Haber RM, Harada T, Kitajima Y, Mallory SB, Ogawa H, Sahin S, Shimizu H, Suga Y, Tadini G, Tsuchiya K, Wiebe CB, Wojnarowska F, Zaghloul AB, Hamada T, Mallipeddi R, Eady RA, McLean WH, McGrath JA, Epstein EH (2003) Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet 73:174–187
244. Sincock PM, Mayrhofer G, Ashman LK (1997) Localization of the transmembrane 4 superfamily (TM4SF) member PETA-3 (CD151) in normal human tissues: comparison with CD9, CD63, and alpha5beta1 integrin. J Histochem Cytochem 45:515–525
245. Sitaru AG, Sesarman A, Mihai S, Chiriac MT, Zillikens D, Hultman P, Solbach W, Sitaru C (2010) T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita. J Immunol 184:1596–1603
246. Sitaru C, Kromminga A, Hashimoto T, Brocker EB, Zillikens D (2002) Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol 161:301–311
247. Sitaru C, Mihai S, Otto C, Chiriac MT, Hausser I, Dotterweich B, Saito H, Rose C, Ishiko A, Zillikens D (2005) Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 115:870–878
248. Sitaru C, Mihai S, Zillikens D (2007) The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases. Arch Dermatol Res 299:1–8
249. Skaria M, Jaunin F, Hunziker T, Riou S, Schumann H, Bruckner-Tuderman L, Hertl M, Bernard P, Saurat JH, Favre B, Borradori L (2000) IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230. J Invest Dermatol 114:998–1004
250. Sonnenberg A, Liem RK (2007) Plakins in development and disease. Exp Cell Res 313:2189–2203
251. Stanley JR (1993) Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol 53:291–325
252. Sterk LM, Geuijen CA, Oomen LC, Calafat J, Janssen H, Sonnenberg A (2000) The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin alpha6beta4 and may regulate the spatial organization of hemidesmosomes. J Cell Biol 149:969–982
253. Sterk LM, Geuijen CA, van den Berg JG, Claessen N, Weening JJ, Sonnenberg A (2002) Association of the tetraspanin CD151 with the laminin-binding integrins alpha3beta1, alpha6beta1, alpha6beta4 and alpha7beta1 in cells in culture and in vivo. J Cell Sci 115:1161–1173
254. Stingl G, Holubar K (1975) Coexistence of lichen planus and bullous pemphigoid. A immunopathological study. Br J Dermatol 93:313–320
255. Takeichi T, Nanda A, Liu L, Aristodemou S, McMillan JR, Sugiura K, Akiyama M, Al-Ajmi H, Simpson MA, McGrath JA (2014) Founder mutation in dystonin-e underlying autosomal recessive epidermolysis bullosa simplex in Kuwait. Br J Dermatol (in press)
256. Talhari C, Althaus C, Megahed M (2006) Ocular linear IgA disease resulting in blindness. Arch Dermatol 142:786–787
257. Tampoia M, Bonamonte D, Filoni A, Garofalo L, Morgese MG, Brunetti L, Di Giorgio C, Annicchiarico G (2013) Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosa. Orphanet J Rare Dis 8:132
258. Tanaka T, Parry DA, Klaus-Kovtun V, Steinert PM, Stanley JR (1991) Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins. J Biol Chem 266:12555–12559
259. Techanukul T, Sethuraman G, Zlotogorski A, Horev L, Macarov M, Trainer A, Fong K, Lens M, Medenica L, Ramesh V, McGrath JA, Lai-Cheong JE (2011) Novel and recurrent FERMT1 gene mutations in Kindler syndrome. Acta Derm Venereol 91:267–270
260. Terra JB, Jonkman MF, Diercks GF, Pas HH (2013a) Low sensitivity of type VII collagen enzyme-linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis. Br J Dermatol 169:164–167
261. Terra JB, Meijer JM, Jonkman MF, Diercks GF (2013b) The n- vs. u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis. Br J Dermatol 169:100–105
262. Thorne JE, Anhalt GJ, Jabs DA (2004) Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology 111:45–52
263. Tindall JG, Rea TH, Shulman I, Quismorio FP Jr (1981) Herpes gestationis in association with a hydatidiform mole. Immunopathologic studies. Arch Dermatol 117:510–512
264. Tsuruta D, Hashimoto T, Hamill KJ, Jones JC (2011) Hemidesmosomes and focal contact proteins: functions and cross-talk in keratinocytes, bullous diseases and wound healing. J Dermatol Sci 62:1–7
265. Tyagi S, Bhol K, Natarajan K, Livir-Rallatos C, Foster CS, Ahmed AR (1996) Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci U S A 93:14714–14719
266. Uitto J, Pulkkinen L, Christiano AM (1994) Molecular basis of the dystrophic and junctional forms of epidermolysis bullosa: mutations in the type VII collagen and kalinin (laminin 5) genes. J Invest Dermatol 103:39S–46S
267. Ussar S, Moser M, Widmaier M, Rognoni E, Harrer C, Genzel-Boroviczeny O, Fassler R (2008) Loss of Kindlin-1 causes skin atrophy and lethal neonatal intestinal epithelial dysfunction. PLoS Genet 4:e1000289
268. Uttam J, Hutton E, Coulombe PA, Anton-Lamprecht I, Yu QC, Gedde-Dahl T Jr, Fine JD, Fuchs E (1996) The genetic basis of epidermolysis bullosa simplex with mottled pigmentation. Proc Natl Acad Sci U S A 93:9079–9084
269. Vafia K, Groth S, Beckmann T, Hirose M, Dworschak J, Recke A, Ludwig RJ, Hashimoto T, Zillikens D, Schmidt E (2012) Pathogenicity of autoantibodies in anti-p200 pemphigoid. PLoS One 7:e41769
270. Van Agtmael T, Bruckner-Tuderman L (2010) Basement membranes and human disease. Cell Tissue Res 339:167–188
271. Van den Bergh F, Eliason SL, Giudice GJ (2011) Type XVII collagen (BP180) can function as a cell-matrix adhesion molecule via binding to laminin 332. Matrix Biol 30:100–108
272. Verraes S, Hornebeck W, Polette M, Borradori L, Bernard P (2001) Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid. J Invest Dermatol 117:1091–1096
273. Vidal F, Aberdam D, Miquel C, Christiano AM, Pulkkinen L, Uitto J, Ortonne JP, Meneguzzi G (1995) Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet 10:229–234
274. Vodegel RM, de Jong MC, Pas HH, Jonkman MF (2002) IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol 47:919–925
275. Vodegel RM, Jonkman MF, Pas HH, de Jong MC (2004) U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol 151:112–118
276. Waisbourd-Zinman O, Ben-Amitai D, Cohen AD, Feinmesser M, Mimouni D, Adir-Shani A, Zlotkin M, Zvulunov A (2008) Bullous pemphigoid in infancy: clinical and epidemiologic characteristics. J Am Acad Dermatol 58:41–48
277. Wakelin SH, Allen J, Zhou S, Wojnarowska F (1998) Drug-induced linear IgA disease with antibodies to collagen VII. Br J Dermatol 138:310–314
278. Wiche G, Winter L (2011) Plectin isoforms as organizers of intermediate filament cytoarchitecture. Bioarchitecture 1:14–20
279. Winter L, Wiche G (2013) The many faces of plectin and plectinopathies: pathology and mechanisms. Acta Neuropathol 125:77–93
280. Wojnarowska F, Marsden RA, Bhogal B, Black MM (1988) Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol 19:792–805
281. Wolf R, Ophir J, Dechner E (1992) Nonbullous bullous pemphigoid. Int J Dermatol 31:498–500
282. Woodley DT (2007) The role of IgE anti-basement membrane zone autoantibodies in bullous pemphigoid. Arch Dermatol 143:249–250
283. Woodley DT, Ram R, Doostan A, Bandyopadhyay P, Huang Y, Remington J, Hou Y, Keene DR, Liu Z, Chen M (2006) Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol 126:1323–1330
284. Wright MD, Geary SM, Fitter S, Moseley GW, Lau LM, Sheng KC, Apostolopoulos V, Stanley EG, Jackson DE, Ashman LK (2004) Characterization of mice lacking the tetraspanin superfamily member CD151. Mol Cell Biol 24:5978–5988
285. Yang Y, Dowling J, Yu QC, Kouklis P, Cleveland DW, Fuchs E (1996) An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments. Cell 86:655–665
286. Yazdanfar A, Hashemi B (2009) Kindler syndrome: report of three cases in a family and a brief review. Int J Dermatol 48:145–149
287. Yiasemides E, Trisnowati N, Su J, Dang N, Klingberg S, Marr P, Melbourne W, Tran K, Chow CW, Orchard D, Varigos G, Murrell DF (2008) Clinical heterogeneity in recessive epidermolysis bullosa due to mutations in the keratin 14 gene, KRT14. Clin Exp Dermatol 33:689–697
288. Yoneda K, Moriue J, Demitsu T, Ishii N, Kubota Y, Hashimoto T (2014) Case of mucous membrane pemphigoid with autoantibodies solely to the gamma2-subunit of laminin-332. J Dermatol (in press)
289. Yuen WY, Jonkman MF (2011) Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature. J Am Acad Dermatol 65:780–789
290. Yuen WY, Lemmink HH, van Dijk-Bos KK, Sinke RJ, Jonkman MF (2011a) Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands. Br J Dermatol 165:1314–1322
291. Yuen WY, Pas HH, Sinke RJ, Jonkman MF (2011b) Junctional epidermolysis bullosa of late onset explained by mutations in COL17A1. Br J Dermatol 164:1280–1284
292. Yuen WY, Pasmooij AM, Stellingsma C, Jonkman MF (2012) Enamel defects in carriers of a novel LAMA3 mutation underlying epidermolysis bullosa. Acta Derm Venereol 92:695–696
293. Yuen WY, Sinke RJ, Jonkman MF (2013) ITGB4-associated non-Herlitz junctional epidermolysis bullosa: report of two new cases carrying two novel ITGB4 mutations. Br J Dermatol 168:432–434
294. Zaidel-Bar R, Geiger B (2010) The switchable integrin adhesome. J Cell Sci 123:1385–1388
295. Zaidel-Bar R, Itzkovitz S, Ma’ayan A, Iyengar R, Geiger B (2007) Functional atlas of the integrin adhesome. Nat Cell Biol 9:858–867
296. Zambruno G, Manca V, Kanitakis J, Cozzani E, Nicolas JF, Giannetti A (1994) Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol 31:884–888
297. Zamir E, Geiger B (2001) Molecular complexity and dynamics of cell-matrix adhesions. J Cell Sci 114:3583–3590
298. Zaraa I, Mahfoudh A, Sellami MK, Chelly I, El Euch D, Zitouna M, Mokni M, Makni S, Ben Osman A (2013) Lichen planus pemphigoides: four new cases and a review of the literature. Int J Dermatol 52:406–412
299. Zillikens D, Kawahara Y, Ishiko A, Shimizu H, Mayer J, Rank CV, Liu Z, Giudice GJ, Tran HH, Marinkovich MP, Brocker EB, Hashimoto T (1996) A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 106:1333–1338
300. Zillikens D, Rose PA, Balding SD, Liu Z, Olague-Marchan M, Diaz LA, Giudice GJ (1997) Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 109:573–579
301. Zillikens D, Caux F, Mascaro JM, Wesselmann U, Schmidt E, Prost C, Callen JP, Brocker EB, Diaz LA, Giudice GJ (1999a) Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. J Invest Dermatol 113:117–121
302. Zillikens D, Herzele K, Georgi M, Schmidt E, Chimanovitch I, Schumann H, Mascaro JM Jr, Diaz LA, Bruckner-Tuderman L, Brocker EB, Giudice GJ (1999b) Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801. J Invest Dermatol 113:947–953
303. Zone JJ, Taylor TB, Meyer LJ, Petersen MJ (1998) The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2. J Invest Dermatol 110:207–210
304. Zone JJ, Egan CA, Taylor TB, Meyer LJ (2004) IgA autoimmune disorders: development of a passive transfer mouse model. J Invest Dermatol Symp Proc 9:47–51
305. Zumelzu C, Le Roux-Villet C, Loiseau P, Busson M, Heller M, Aucouturier F, Pendaries V, Lievre N, Pascal F, Brette MD, Doan S, Charron D, Caux F, Laroche L, Petit A, Prost-Squarcioni C (2011) Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita. J Invest Dermatol 131:2386–2393